跳至主要内容
临床试验/NCT03054740
NCT03054740已完成4 期

Will Patients Perceive a Vapocoolant Spray to be Effective in Reducing Pain and Increasing Satisfaction With Insertion at an Intravenous Site?

Aultman Health Foundation1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年2月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Pain Scale Using Visual Analog Scale

研究概览

简要总结

The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.

详细描述

This is a single blind interventional study with a post design using a convenience sample of patients undergoing a Nuclear Medicine Stress Test. The patient selection and intervention will be randomized in order to ensure a high validity study. The interventional treatment used will be a ethyl chloride mist spray manufactured by the Gebauer Company. The placebo spray that will be used is manufactured by BioLogic Aqua Research Technologies International Inc. The spray is called Nature's Tears Mist and is a sterile water. The patient's for this study are required to have intravenous cannulation (IV) access. This is a painful and invasive procedure in which a vapocoolant may confer benefit for the relief of pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any outpatient ordered to undergo a Nuclear Medicine Stress Test and is required to have IV access for injection of Radiopharmaceuticals

排除标准

  • If it is the first time the patient has had an intravenous catheter inserted
  • Any patient who is or may be pregnant
  • Any patient who is breast-feeding
  • Any patient who has taken a narcotic, sedative and/or anti-anxiety medication within 8 hours of intervention time.
  • Any patient who has a known diagnosis of Raynaud's Syndrome or Carpal Tunnel Syndrome.
  • Any patient who has an allergy or hypersensitivity to Ethyl Chloride.
  • Any patient under the age of 18 and/or any patient over the age of 85
  • Any patient who is illiterate
  • Any patient who is non-English speaking
  • Any patient with prior experience with a vapocoolant spray.

研究组 & 干预措施

Gebauer Ethyl Chloride

Active Comparator

Device: Vapocoolant (Ethyl Chloride Mist Spray)

干预措施: Gebauer Ethyl Chloride (Drug)

Nature's Tears

Placebo Comparator

Device: Sterile Water

干预措施: Nature's Tears (Drug)

结局指标

主要结局

Pain Scale Using Visual Analog Scale

时间窗: less than 5 minutes following spray application

0-No Pain; 1-3 Mild Pain; 4-6 Moderate-Severe Pain; 7-9 Very Severe Pain;10 Worst Possible Pain

次要结局

  • Satisfaction Scale Using 1-5 Likert Scale(less than 5 minutes following spray application)
  • Would Patient Choose to Have Intervention Again if IV Catheter Insertion is Needed(less than 10 minutes following spray application)
  • Using the Same Visual Analog Scale Rate Pain the Last Time the Patient Remembers Having an IV Inserted(At baseline prior to spray application)
  • Using the Same Likert Scale Rate How Satisfied the Patient Remembers the Last Time They Had IV Catheter Inserted(At baseline prior to spray application)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验